HomeBIO • NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$332.91
After Hours:
$332.91
(0.00%)0.00
Closed: Nov 22, 6:01:45 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$325.58
Day range
$321.62 - $334.71
Year range
$262.12 - $387.99
Market cap
9.37B USD
Avg Volume
202.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
CDP Climate Change Score
D-
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
649.73M2.79%
Operating expense
291.34M19.14%
Net income
653.17M514.71%
Net profit margin
100.53498.04%
Earnings per share
2.01-13.73%
EBITDA
103.47M-19.45%
Effective tax rate
24.19%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
1.62B-7.76%
Total assets
10.60B-10.86%
Total liabilities
3.12B-10.46%
Total equity
7.49B
Shares outstanding
28.00M
Price to book
1.22
Return on assets
1.59%
Return on capital
1.89%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
653.17M514.71%
Cash from operations
163.56M67.39%
Cash from investing
-55.64M-485.64%
Cash from financing
-95.99M-260.88%
Net change in cash
4.47M-93.41%
Free cash flow
23.87M-46.32%
About
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
Founded
1952
Employees
8,030
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu